Skip to main content
Top
Published in: Translational Stroke Research 2/2018

01-04-2018 | Letter to the Editor

Precision Medicine for Ischemic Stroke, Let Us Move Beyond Time Is Brain

Authors: Shao-Hua Yang, Min Lou, Benyan Luo, Wei-Jian Jiang, Ran Liu

Published in: Translational Stroke Research | Issue 2/2018

Login to get access

Excerpt

Until 1995, treatment of ischemic stroke consisted exclusively of efforts to prevent recurrence. Since that time, the introduction of recombinant tissue plasminogen activator (rtPA) treatment has significantly improved morbidity and mortality of ischemic stroke [1]. Ischemic stroke is treatable but time is critical. The term “time is brain” has been coined for acute stroke intervention, even before the rtPA trials, to emphasize that the human brain is rapidly and irreversibly lost as stroke progresses and that therapeutic interventions should be emergently pursued [25]. Two decades after the approval of intravenous rtPA for the treatment of ischemic stroke, interventions to reopen an occluded artery through thrombolysis and mechanical thrombectomy remain the only and first priority in ischemic stroke treatment. Accordingly, dramatic effort has been investing to reduce the time from stroke onset to treatment and arrival-to-puncture time for ischemic stroke patients. It is anticipated that an interdisciplinary and rapid response to the emergence of stroke intervention can result in dramatic impact of thrombolysis on this public health problem. Unfortunately, the number of ischemic stroke patients who are treated with thrombolytic therapy is still disappointingly low. …
Literature
1.
go back to reference The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.
3.
6.
go back to reference Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40:2945–8.CrossRefPubMedPubMedCentral Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40:2945–8.CrossRefPubMedPubMedCentral
7.
8.
go back to reference Yu W, Kostanian V, Fisher M. Endovascular recanalization of basilar artery occlusion 80 days after symptom onset. Stroke. 2007;38:1387–9.CrossRefPubMed Yu W, Kostanian V, Fisher M. Endovascular recanalization of basilar artery occlusion 80 days after symptom onset. Stroke. 2007;38:1387–9.CrossRefPubMed
9.
go back to reference Molina CA. Futile recanalization in mechanical embolectomy trials: a call to improve selection of patients for revascularization. Stroke. 2010;41:842–3.CrossRefPubMed Molina CA. Futile recanalization in mechanical embolectomy trials: a call to improve selection of patients for revascularization. Stroke. 2010;41:842–3.CrossRefPubMed
10.
11.
go back to reference Galimanis A, Jung S, Mono ML, Fischer U, Findling O, Weck A, et al. Endovascular therapy of 623 patients with anterior circulation stroke. Stroke. 2012;43:1052–7.CrossRefPubMed Galimanis A, Jung S, Mono ML, Fischer U, Findling O, Weck A, et al. Endovascular therapy of 623 patients with anterior circulation stroke. Stroke. 2012;43:1052–7.CrossRefPubMed
12.
go back to reference Lansberg MG, Cereda CW, Mlynash M, Mishra NK, Inoue M, Kemp S, et al. Response to endovascular reperfusion is not time-dependent in patients with salvageable tissue. Neurology. 2015;85:708–14.CrossRefPubMedPubMedCentral Lansberg MG, Cereda CW, Mlynash M, Mishra NK, Inoue M, Kemp S, et al. Response to endovascular reperfusion is not time-dependent in patients with salvageable tissue. Neurology. 2015;85:708–14.CrossRefPubMedPubMedCentral
13.
go back to reference Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064–89.CrossRefPubMed Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064–89.CrossRefPubMed
15.
go back to reference Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056–83.CrossRefPubMed Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056–83.CrossRefPubMed
16.
go back to reference Bivard A, Levi C, Krishnamurthy V, McElduff P, Miteff F, Spratt NJ, et al. Perfusion computed tomography to assist decision making for stroke thrombolysis. Brain. 2015;138:1919–31.CrossRefPubMedPubMedCentral Bivard A, Levi C, Krishnamurthy V, McElduff P, Miteff F, Spratt NJ, et al. Perfusion computed tomography to assist decision making for stroke thrombolysis. Brain. 2015;138:1919–31.CrossRefPubMedPubMedCentral
17.
go back to reference Gonzalez RG. Imaging-guided acute ischemic stroke therapy: from “time is brain” to “physiology is brain”. AJNR Am J Neuroradiol. 2006;27:728–35.PubMed Gonzalez RG. Imaging-guided acute ischemic stroke therapy: from “time is brain” to “physiology is brain”. AJNR Am J Neuroradiol. 2006;27:728–35.PubMed
19.
go back to reference Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008;7:299–309.CrossRefPubMed Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008;7:299–309.CrossRefPubMed
20.
go back to reference Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 2012;11:860–7.CrossRefPubMedPubMedCentral Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 2012;11:860–7.CrossRefPubMedPubMedCentral
21.
go back to reference Alawneh J, Baron J-C. Penumbral imaging in acute stroke: a triumph of hope over experience? ACNR. 2014;14:18–23. Alawneh J, Baron J-C. Penumbral imaging in acute stroke: a triumph of hope over experience? ACNR. 2014;14:18–23.
22.
go back to reference Agarwal S, Warburton EA, Baron JC. From time is brain to physiology is brain: a case for reflection in acute stroke treatment decisions. Brain. 2015;138:1768–70.CrossRefPubMed Agarwal S, Warburton EA, Baron JC. From time is brain to physiology is brain: a case for reflection in acute stroke treatment decisions. Brain. 2015;138:1768–70.CrossRefPubMed
24.
go back to reference Dani KA, Warach S. Metabolic imaging of ischemic stroke: the present and future. AJNR Am J Neuroradiol. 2014;35:S37–43.CrossRefPubMed Dani KA, Warach S. Metabolic imaging of ischemic stroke: the present and future. AJNR Am J Neuroradiol. 2014;35:S37–43.CrossRefPubMed
25.
go back to reference Mandal PK. Brain metabolic mapping with MRS: a potent noninvasive tool for clinical diagnosis of brain disorders. AJNR Am J Neuroradiol. 2014;35:S1–3.CrossRefPubMed Mandal PK. Brain metabolic mapping with MRS: a potent noninvasive tool for clinical diagnosis of brain disorders. AJNR Am J Neuroradiol. 2014;35:S1–3.CrossRefPubMed
26.
go back to reference Christen T, Bolar DS, Zaharchuk G. Imaging brain oxygenation with MRI using blood oxygenation approaches: methods, validation, and clinical applications. AJNR Am J Neuroradiol. 2013;34:1113–23.CrossRefPubMed Christen T, Bolar DS, Zaharchuk G. Imaging brain oxygenation with MRI using blood oxygenation approaches: methods, validation, and clinical applications. AJNR Am J Neuroradiol. 2013;34:1113–23.CrossRefPubMed
Metadata
Title
Precision Medicine for Ischemic Stroke, Let Us Move Beyond Time Is Brain
Authors
Shao-Hua Yang
Min Lou
Benyan Luo
Wei-Jian Jiang
Ran Liu
Publication date
01-04-2018
Publisher
Springer US
Published in
Translational Stroke Research / Issue 2/2018
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-017-0566-y

Other articles of this Issue 2/2018

Translational Stroke Research 2/2018 Go to the issue